Please set your pop-up blockers to allow pop-ups on www.peerviewpress.com. We use pop-ups to display content. Click Help for more information.

FEATURED PRESENTATION

Clinical Benefits of Anti-Angiogenic Agents in First-Line NSCLC: Benchtop to Clinical Practice

Interviewees
Frank Griesinger, MD, PhD
Lucio Crinò, MD
Nicholas Thatcher, MB, BChir, PhD, FRCP

2010-01-22
Audio - Clinical Benefits of Anti-Angiogenic Agents in First-Line NSCLC: Benchtop to Clinical Practice
Frank Griesinger, MD, PhD
University of Goettingen
Pius-Hospital
Oldenburg, Germany
Audio - New Combinations for First-Line Therapy in NSCLC: Improving Survival With Anti-Angiogenic Agents
Frank Griesinger, MD, PhD
University of Goettingen
Pius-Hospital
Oldenburg, Germany Download this Presentation's Materials
Slides
Printable Transcript
MP3
Audio - The Safety Profile of Anti-Angiogenic Therapy With Standard Chemotherapy for NSCLC
Lucio Crinò, MD
Perugia University Hospital
Perugia, Italy
Download this Presentation's Materials
Slides
Printable Transcript
MP3
Audio - Safety With Anti-Angiogenic Therapies: An In-Depth Look
Nicholas Thatcher, MB, BChir, PhD, FRCP
Christie Hospital NHS Trust
Manchester, United Kingdom
Download this Presentation's Materials
Slides
Printable Transcript
MP3
2009-03-01 Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer
2007-12-01 Inhibition of angiogenesis in the treatment of non-small cell lung cancer
2008-06-01 Targeted therapy in advanced non-small-cell lung cancer
2007-02-01 Dual targeting of the vascular endothelial growth factor and epidermal growth factor receptor pathways: rationale and clinical applications for non-small-cell lung cancer
2008-06-01 Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?
2009-01-01 Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy